Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04396002 · ClinicalTrials.gov registry record
Glaucoma, Visual Field Loss, and Their Association With Life Space in Older Adults
A clinical trial of Primary Open Angle Glaucoma, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT04396002 is a study of Primary Open Angle Glaucoma that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 100 participants, below the 289-participant average among 19 other Primary Open Angle Glaucoma trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04396002, a study of Primary Open Angle Glaucoma, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Mobility refers to a person's purposeful movement through the environment from one place to another and can be conceptualized as a continuum from bed bound (immobility) on one extreme to making excursions to distant locations on the other extreme. Primary open-angle glaucoma (POAG) is a chronic, progressive optic neuropathy that can lead to gradual loss of vision in the peripheral field and central vision. Older adults with POAG have an increased risk for motor vehicle collisions and falls. Moreover, existing studies suggest that patients with POAG exhibit more postural sway while standing as measured by a balance platform and also tend to walk more slowly than those who are normally sighted and free of ocular disease. While these disturbances likely influence mobility, there has been little research directly assessing the impact of POAG on mobility. This study will assess the impact of POAG on life space (one aspect of mobility) and will determine whether difficulties with life space are associated with difficulties experienced under conditions of dim lighting.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Life Space Questionnaire
- DIAGNOSTIC_TEST Low Luminance Questionnaire
- DIAGNOSTIC_TEST Contrast sensitivity under dim illumination
- DIAGNOSTIC_TEST Visual field under dim illumination (MAIA)
- DIAGNOSTIC_TEST Macular Pigment Optical Density (MPOD)
Study Locations (1)
Alabama
- University of Alabama Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-06-01 |
| Est. Completion | 2026-05-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04396002
The ClinicalTrials.gov registry entry for NCT04396002 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 289-participant average among 19 other Primary Open Angle Glaucoma trials with a reported enrollment target (65% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Primary Open Angle Glaucoma appearing as the primary indexed condition, and to 5 interventions - of which Life Space Questionnaire is the first listed.
NCT04396002 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT04396002 about?
NCT04396002 is a clinical study titled "Glaucoma, Visual Field Loss, and Their Association With Life Space in Older Adults". Mobility refers to a person's purposeful movement through the environment from one place to another and can be conceptualized as a continuum from bed bound (immobility) on one extreme to making excursions to distant locations on the other extreme. Primary open-angle glaucoma (POAG) is a chronic, pro...
What is the current status of trial NCT04396002?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2019-06-01. Estimated completion is 2026-05-30.
What conditions does trial NCT04396002 study?
This clinical trial studies the following conditions: Primary Open Angle Glaucoma.
What interventions are being tested in trial NCT04396002?
The interventions under investigation include: Life Space Questionnaire (DIAGNOSTIC_TEST), Low Luminance Questionnaire (DIAGNOSTIC_TEST), Contrast sensitivity under dim illumination (DIAGNOSTIC_TEST), Visual field under dim illumination (MAIA) (DIAGNOSTIC_TEST), Macular Pigment Optical Density (MPOD) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04396002?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04396002 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Open Angle Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma
RECRUITING · Phase 2
-
DSLT for Reducing Medication in Glaucoma
RECRUITING
-
A Prospective Study on the Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in Achieving >20% Intraocular Pressure (IOP) Reduction Without Medications at 6 Months in Naive, Untreated Glaucoma Patients
RECRUITING
-
Hydrus® Microstent New Enrollment Post-Approval Study
RECRUITING · NA
-
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
RECRUITING · NA
-
Diagnostic Innovations in Glaucoma Study
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.